Given the therapeutic potential of AAV8‐hAAT‐FGF21 for the treatment of obesity and diabetes, we evaluated the long‐term effects of gene transfer on the bones of the animals treated with the highest dose of vector. This evidence concerns the gene FGF21 and diabetes mellitus.